Spruce Biosciences Reports First Quarter 2021 Financial Results …
First Quarter 2021 Financial Results. Cash and Cash Equivalents: Cash and cash equivalents as of March 31, 2021, were $148.6 million. Research and Development (R&D) Expenses: R&D …
OFF
Spruce Biosciences Reports First Quarter 2021 Financial Results …
6 days from now
First Quarter 2021 Financial Results. Cash and Cash Equivalents: Cash and cash equivalents as of March 31, 2021, were $148.6 million. Research and Development (R&D) Expenses: R&D …
sprucebio.com
OFF
SPRB - Spruce Biosciences Inc Stock Price And Quote - FINVIZ.com
6 days from now
Spruce Biosciences Added to Russell 2000®, 3000® and Microcap® Indexes. (Business Wire) -5.42%. Spruce Biosciences, Inc. is a late-stage biopharmaceutical company, which engages in …
finviz.com
OFF
Spruce Biosciences Reports Fourth Quarter And Full Year 2021 …
6 days from now
Fourth Quarter and Full Year 2021 Financial Results Cash, Cash Equivalents and Investments: Cash, cash equivalents and investments as of December 31, 2021 , were $121.4 million , …
sprucebio.com
OFF
Spruce Biosciences Reports Full Year 2022 Financial Results And ...
6 days from now
Net Loss: Net loss for the year ended December 31, 2022 was $46.2 million compared to $42.3 million in 2021. About Spruce Biosciences. Spruce Biosciences is a late-stage …
sprucebio.com
OFF
Spruce Biosciences Reports First Quarter 2022 Financial Results …
6 days from now
First Quarter 2022 Financial Results Cash, Cash Equivalents and Investments: Cash, cash equivalents and investments as of March 31, 2022 , were $108.9 million . Research and …
sprucebio.com
OFF
Akoya Biosciences Reports Third Quarter 2024 Financial Results
6 days from now
Sep 30, 2024 · Third Quarter 2024 Financial Results. For the third quarter of 2024, revenue was $18.8 million, a 25% year-over-year decrease from $25.2 million in the third quarter of 2023. …
nasdaq.com
OFF
Akoya Biosciences Reports Third Quarter 2024 Financial
6 days from now
Nov 14, 2024 · Third Quarter 2024 Financial Results. For the third quarter of 2024, revenue was $18.8 million, a 25% year-over-year decrease from $25.2 million in the third quarter of 2023. …
globenewswire.com
OFF
Spruce Biosciences Reports Third Quarter 2021 Financial Results …
6 days from now
Third Quarter 2021 Financial Results Cash, Cash Equivalents and Investments: Cash, cash equivalents and investments as of September 30, 2021 , were $131.3 million . Research and …
sprucebio.com
OFF
Spruce Biosciences Reports Second Quarter 2021 Financial Results …
6 days from now
Second Quarter 2021 Financial Results Cash, Cash Equivalents and Investments: Cash, cash equivalents and investments as of June 30, 2021 , were $139.0 million . Research and …
sprucebio.com
OFF
Spruce Biosciences Reports Third Quarter 2021 Financial Results …
6 days from now
Nov 15, 2021 · Third Quarter 2021 Financial Results Cash, Cash Equivalents and Investments: Cash, cash equivalents and investments as of September 30, 2021, were $131.3 million.
businesswire.com
FAQs about Spruce Biosciences Reports First Quarter 2021 Financial Results … Coupon?
Is spruce Biosciences Inc (SPRB) a good stock to buy?
What does spruce Biosciences do?
Where can I learn more about spruce Biosciences?
Where can I contact spruce Biosciences?
What are the operating expenses of Sprout Biosciences?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
